project id: TCGA-HNSC; case submitter id: TCGA-CN-A63T; source center: 23; state: released; a260 a280 ratio: 1.96; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 7.7; age at index: 60; days to birth: -22201; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22201; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T3; ajcc pathologic m: MX; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 225.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 2.5205479452054793; pack years smoked: 46.0; years smoked: 46.0; is ffpe: false; composition: Not Reported; days to collection: 519; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-CN-A63T-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 30.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;